CureVac NV sues BioNTech for IP infringeme...German mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued BioNTech/Pfizer for infringement of four patents. more ➔
French Ipsen falls after Epizyme take-over...Shares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US cancer specialist Epizyme Inc. for $247m. more ➔
TWB announces winners in industrial biotec...At the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth €50,000. more ➔
BIONTech breaks ground for manufacturing s...BioNTech SE has announced it is going to ship the first containers for mRNA malaria vaccine production from this years end toKigall. more ➔
Cannabis players Canify AS and Bavaria Wee...In an effort to become a major player in Europes growing pharmaceutical-grade cannabis market, Danish Canify AS and Bavaria Weed GmbH merge to form Canify AG. more ➔
Unilever launches $120m venture with Genom...Under the $120m deal, Genomatica and Unilever will scale plant- and waste-based alternative to palm oil and fossil fuels. more ➔
Roche obtains special authorisation for bi...Roche obtained from European Medicine Agency (EMA) a special authorization (conditional approval) for new bispecific antibody Lunsumio for treatment of relapsed or refractory follicular (R/R) lymphoma … more ➔
Andera Partners, Imcheck therapeutics, Kurma, marseille, Pfizer, wellington French ImCheck get´s a USD103m check by P... ImCheck Therapeutics located in Marseille, France, announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird and Andera Partners. Kurma Partners, Eurazeo, Gimv, … more ➔
$50m for London CHARM Therapeutics for dee... CHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology. more ➔
Biotalys first proteinbased biocontrol s... Based on data from the latest trials in grapes across vineyards in diverse climates throughout California and New York, Biotalys’ biocontrol product Evoca provided superior preventative control of Botrytis … more ➔
